Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office

May 15 2013

• By Derrick Gingery

Related Content

CDER Taps Genzyme Exec As Deputy Director For Science Operations

Feb 13 2013

FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss

May 06 2013

Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties

Jan 23 2013

FDA Leadership Challenge: Temporary Medical Products Office Head Departs; Replacement Unknown

May 03 2013

FDA Generics Director’s Departure Shows Why Chemistry Matters

Mar 18 2013

FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus

Jul 18 2011

FDA Reorganization Creates Prominent Roles For Mercy Hospital's Spielberg, CDER's Autor

Jul 13 2011

FDA's Spielberg To Focus On Cross-Center Collaboration, Hamburg Says

Aug 01 2011

Related Companies

Viatris Inc.

Johnson & Johnson

Novartis AG

Merck & Co., Inc.

Sanofi Genzyme

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window